|
?:authorAffiliation
|
-
[\'Medical Intensive Care Unit, Hospital Clinic, Barcelona, Spain.\', \'Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, Spain.\', \'Barcelona Endothelium Team, Barcelona, Spain.\', \'IDIBAPS, Barcelona, Spain.\', \'Josep Carreras Leukaemia Research Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.\', \'School of Medicine, University of Barcelona, Barcelona, Spain.\', \'Frank H. Netter M.D. School of Medicine at Quinnipiac University, North Haven, Connecticut.\', \'Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.\', \'Hematopoietic Transplant and Cellular Therapy Unit, Instituto Murciano de Investigación Biosanitaria IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Murcia, Spain.\', \'Department of Oncology and Hematology, Humanitas Clinical and Research Center-IRCCS, Rozzano-Milano, Italy.\', \'Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy.\', \'Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, Massachusetts.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}